WeLeader Biomedical Co., Ltd.
WeLeader Biomedical Co., Ltd. operates as an agent and distributor of in vitro diagnostic products. It offers a range of medical testing systems, such as serum biochemistry integration platform, clinical care, and medical information integration system. The company also provides blood gas electrolyte analyzers, urine analyzers, integrated fully automatic biochemical analyzers, fully automatic ele… Read more
WeLeader Biomedical Co., Ltd. (7713) - Net Assets
Latest net assets as of : NT$- TWD
Based on the latest financial reports, WeLeader Biomedical Co., Ltd. (7713) has net assets worth NT$- TWD as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$-) and total liabilities (NT$-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
WeLeader Biomedical Co., Ltd. - Net Assets Trend (None–None)
This chart illustrates how WeLeader Biomedical Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for WeLeader Biomedical Co., Ltd. (None–None)
The table below shows the annual net assets of WeLeader Biomedical Co., Ltd. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to WeLeader Biomedical Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
WeLeader Biomedical Co., Ltd. Competitors by Market Cap
The table below lists competitors of WeLeader Biomedical Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SUN INTL RC-08
F:RY1B
|
$21.02K |
|
LS Networks Corp. Ltd.
KQ:000680
|
$21.05K |
|
TAURON
MU:1T5
|
$21.07K |
|
Crystalvue Medical Corporation
TWO:6527
|
$21.08K |
|
Mari Petroleum Company Ltd
KAR:MARI
|
$21.01K |
|
E-Elements Technology Co., Ltd.
TWO:6842
|
$21.01K |
|
Med Life S.A.
F:O0C
|
$20.98K |
|
Goldenstone Acquisition Limited Warrants
NASDAQ:GDSTW
|
$20.98K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in WeLeader Biomedical Co., Ltd.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares WeLeader Biomedical Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently WeLeader Biomedical Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares WeLeader Biomedical Co., Ltd.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,274,214,400
- Average return on equity (ROE) among peers: 6.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| WeLeader Biomedical Co., Ltd. (7713) | NT$- | N/A | N/A | $21.02K |
| Health & Life Co., Ltd. (1781) | $372.58 Million | -4.71% | 1.15x | $12.97 Million |
| Hi-Clearance (1788) | $3.00 Billion | 11.98% | 0.65x | $104.25 Million |
| Radiant Innovation (3373) | $865.89 Million | -3.30% | 0.08x | $18.65 Million |
| Wellell Inc (4106) | $1.31 Billion | 13.81% | 0.24x | $37.12 Million |
| Rossmax International Ltd (4121) | $1.33 Billion | 1.93% | 1.30x | $38.32 Million |
| United Orthopedic (4129) | $1.77 Billion | 7.55% | 0.46x | $300.33 Million |
| Dynamic Medical Technologies (4138) | $1.76 Billion | 11.67% | 0.71x | $39.41 Million |
| Ok Biotech Co Ltd (4155) | $1.30 Billion | 9.66% | 0.71x | $44.61 Million |
| Bioptik Technology (4161) | $717.83 Million | 6.76% | 1.11x | $30.42 Million |
| EPS Bio Technology Corp. (4183) | $309.15 Million | 10.25% | 0.77x | $4.27 Million |